Related Experiment Video

Updated: Jun 13, 2026

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

TIMP-3 promotes apoptosis in nonadherent small cell lung carcinoma cells lacking functional death receptor pathway

Janne P Kallio1, Sally Hopkins-Donaldson, Andrew H Baker

  • 1Department of Dermatology, University of Turku and Turku University Hospital and MediCity Research Laboratory, University of Turku, Turku, Finland.

International Journal of Cancer
|May 18, 2010
PubMed

Insights

Tissue inhibitor of metalloproteinases-3 (TIMP-3) shows potential as an anticancer therapeutic. Adenoviral delivery of TIMP-3 induced apoptosis in small cell lung cancer cells, even without caspase-8 activation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a known tumor suppressor for adherent cells.
  • TIMP-3 normally inhibits cell adhesion and promotes apoptosis via caspase-8.
  • Small cell lung cancer (SCLC) cell lines often grow in suspension and lack functional caspase-8.

Purpose of the Study:

  • To investigate the therapeutic potential of TIMP-3 in SCLC.
  • To determine if TIMP-3 can induce apoptosis in SCLC cells lacking functional caspase-8.
  • To explore TIMP-3 as a novel anticancer agent for non-adherent cancers.

Main Methods:

  • Adenoviral delivery of TIMP-3 into SCLC cell lines (SW2 and N417).
  • Assessment of apoptotic cell death induction.
  • Evaluation of caspase-8 activation status.

Main Results:

  • Adenoviral TIMP-3 overexpression successfully induced apoptotic cell death in SCLC cells.
  • Apoptosis occurred independently of caspase-8 activation.
  • TIMP-3 demonstrated efficacy in non-adherent SCLC models.

Conclusions:

  • TIMP-3 can trigger apoptosis in SCLC cells irrespective of caspase-8 functionality.
  • TIMP-3 represents a promising therapeutic candidate for non-adherent cancers.
  • This study expands the therapeutic applicability of TIMP-3 in oncology.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...